Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
09/09/2024

Archive: 09/09/2024

Study deciphers pathological mechanisms of spermatogenic impairment in cryptorchidism

Cryptorchidism is a common congenital abnormality in male newborns. Studies have found that cryptorchidism is associated with a high prevalence of male infertility, with nearly 10% of men with fertility problems having a ...

Sep 9, 2024

0

0

AI shows promise for precision inflammatory bowel disease management

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are chronic conditions that significantly impact patients' quality of life. While significant advancements have been made in treatment options, ...

Sep 9, 2024

0

0

Alzheimer's study: Drug combination improves memory skills in mice

Laboratory mice with cognitive issues including Alzheimer's disease showed improved memory skills within a couple of weeks of treatment with a new medicine tested at Colorado State University.

Sep 9, 2024

0

0

AI tool reveals cardiac risk for patients undergoing cancer therapy

In a new study published in Circulation: Cardiovascular Quality and Outcomes, researchers at Yale School of Medicine say an artificial intelligence (AI) tool can use electrocardiographic (ECG) images to define the risk of ...

Sep 9, 2024

0

0

UK report reveals six ways that care homes support older people to thrive

Research from City St George's, University of London (My Home Life England initiative) reveals the breadth of experiences of older people living in care homes across the UK.

Sep 9, 2024

0

0

Studies provide first evidence that breastfeeding after breast cancer is safe

According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation (an inherited change in BRCA genes ...

Sep 9, 2024

0

0

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

The combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response rate compared to osimertinib alone, according to research presented at the International Association for the Study ...

Sep 9, 2024

0

0

Zongertinib demonstrates promising efficacy in patients with HER2-mutant non-small cell lung cancer

The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated promising efficacy in patients with HER2 mutation-positive non-small cell lung cancer, meeting the primary endpoint of the Beamion ...

Sep 9, 2024

0

0

BAY 2927088 demonstrates 'rapid, substantial and durable responses' in patients with HER2-mutant NSCLC

Treatment with BAY 2927088 led to rapid, substantial, and durable responses in patients with heavily pretreated HER2-mutant non-small cell lung cancer (NSCLC), according to research presented at the International Association ...

Sep 9, 2024

0

0

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

The tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung cancer across a broad range of EGFR PACC mutations in the first-line metastatic setting with CNS antitumor activity, ...

Sep 9, 2024

0

0

page 5 from 11

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us